- Home
- FMS
as of 11-28-2025 12:33pm EST
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
| Founded: | 1996 | Country: | Germany |
| Employees: | N/A | City: | N/A |
| Market Cap: | 14.1B | IPO Year: | 1996 |
| Target Price: | $30.00 | AVG Volume (30 days): | 560.1K |
| Analyst Decision: | Sell | Number of Analysts: | 2 |
| Dividend Yield: | Dividend Payout Frequency: | Annual | |
| EPS: | 2.86 | EPS Growth: | 8.62 |
| 52 Week Low/High: | $21.83 - $30.46 | Next Earning Date: | 11-04-2025 |
| Revenue: | $23,046,819,198 | Revenue Growth: | 2.10% |
| Revenue Growth (this year): | 1.75% | Revenue Growth (next year): | 3.01% |
AI-Powered FMS Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare FMS vs Leading Stocks
See how FMS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "FMS Fresenius Medical Care AG - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.